D-Wave Quantum's Stock Valuation Outpaces Its Roadmap

Alan Baratz has been CEO of D-Wave Quantum since 2020, long enough to have survived multiple hype cycles, one SPAC listing, and the kind of investor scrutiny that comes when a company's stock price and its technology roadmap are moving in opposite directions. In recent earnings calls and public appearances, Baratz has consistently framed D-Wave's position as a feature rather than a bug — arguing that annealing-based quantum computing already delivers practical results for optimization problems today, while gate-model competitors are still years away from fault-tolerant systems that work reliably outside a lab. The pitch is essentially: we're the only ones shipping. The market's response has been skeptical, and that skepticism is now backed by some fairly specific structural concerns.

The bear case against D-Wave (NYSE: QBTS), laid out in detail by Seeking Alpha, rests on three interlocking problems that the current valuation doesn't adequately price. Revenue lags peers. The technology roadmap has slipped. And the company just absorbed a supply chain dependency risk that, depending on how one deal plays out, could quietly strangle its core hardware program.

Start with the technology positioning, because Baratz's reframing of it is genuinely interesting even if it isn't fully convincing. D-Wave uses quantum annealing — a specialized approach optimized for a class of combinatorial problems (think logistics routing, financial portfolio optimization, drug discovery scheduling) rather than the general-purpose gate-model architecture that companies like IonQ and Quantinuum are building toward. When analysts push on roadmap slippage, Baratz's public posture has been to redirect the conversation toward customer deployments: real enterprises using D-Wave's Leap cloud platform for real optimization problems, today, rather than waiting for a fault-tolerant future that nobody has actually delivered yet.

That's a coherent argument. Whether it's a durable business model or a pivot story dressed up as a strategy is the part that warrants more scrutiny.

Here's what makes the competitive landscape uncomfortable for D-Wave specifically: the companies best positioned for the long-term upside are also the ones making D-Wave's near-term advantages shrink. According to a Motley Fool comparison of quantum computing stocks, IonQ and Quantinuum lead the field on accuracy — which matters because high error rates are the central obstacle to making quantum computing practical at scale. D-Wave's annealing approach sidesteps the error-correction problem by operating in a narrower domain, but that domain narrowness is exactly what caps the upside. If gate-model systems get their error rates under control, D-Wave's "we're shipping today" advantage doesn't compound — it erodes.

The supply chain issue sharpens this further. Seeking Alpha's analysis of QBTS flags something that hasn't gotten enough attention in the general coverage: D-Wave depends heavily on SkyWater Technology for its chip fabrication. SkyWater is now subject to an acquisition by IonQ — D-Wave's most direct competitor in the commercial quantum market. The logic of what follows isn't complicated. A competitor that controls your fab has every incentive to treat your production schedule as a lower priority than its own. D-Wave doesn't have an obvious alternative ready at scale. If IonQ's acquisition closes and SkyWater's management turns its attention inward, D-Wave's annealing hardware roadmap — already described as delayed — faces a supply constraint that no amount of customer traction messaging can paper over.

Meanwhile, D-Wave is simultaneously trying to execute a dual-platform strategy, integrating gate-model capabilities alongside its annealing architecture after acquiring Quantum Circuits Inc. According to Motley Fool's D-Wave vs. Rigetti comparison, the successful integration of QCI is vital to this pivot — and any stumble there compounds the capital risk, because D-Wave is already running persistent operating losses and depends on external funding to sustain the development roadmap. The SkyWater problem isn't just a supply chain problem; it's a capital allocation problem dressed in a fab coat. You can't raise the next funding round on a dual-platform growth story while your primary hardware platform is waiting on a fab your competitor now controls.

The $2.7 trillion figure that keeps getting cited — McKinsey & Company's projection for quantum computing's global economic value by 2035, referenced by both Motley Fool and The Globe and Mail — is real, and the opportunity it describes is real. The question isn't whether quantum computing matters. It's whether D-Wave captures enough of that value to justify today's stock price, given who else is competing for it and how the technical landscape is shifting under their feet.

Quantum's timeline problem is distinct from other deep-tech bets in a way that makes the valuation math especially treacherous. With autonomous vehicles, the "when" question was mostly a sensor and software problem — the underlying physics was settled. With gene therapy, clinical trial timelines are regulatory and biological, but the therapeutic logic compounds predictably. Quantum computing has a harder constraint: the error-correction problem is both unsolved and the thing that determines whether the entire category scales. Every pure-play quantum company is burning capital against a physics problem that may or may not yield on anyone's preferred schedule. D-Wave's bet is that you don't need to solve it if you stay in the narrow lane where annealing works. That's a real bet. It just also means D-Wave's total addressable market has a ceiling that IonQ and Quantinuum's doesn't.

Motley Fool's July analysis of quantum computing stocks flagged $988 million in combined net losses projected across IonQ, Rigetti, and D-Wave — a sector-wide capital burn figure that underscores how far the industry still sits from self-sustaining economics. For context: that's not a company-specific number, it's the collective cash consumption of three listed pure-plays, none of which has cracked the code on revenue scale. In that company, D-Wave isn't uniquely distressed — but it is uniquely exposed, because its competitors are also its potential supply chain landlords.

Baratz isn't wrong that D-Wave has something real: paying customers, deployed systems, optimization problems being solved today rather than in a speculative future. That's worth something. The uncomfortable question is whether it's worth this stock price, against this set of compounding risks — a delayed roadmap, a fab dependency being absorbed by a competitor, a dual-platform integration that still needs to prove itself, and an operating model that requires external capital to keep the whole structure standing. Each of those risks feeds the next.

The McKinsey $2.7 trillion opportunity will materialize for someone. The market is currently debating whether D-Wave is the company that captures it, or the cautionary tale that explains why being early isn't the same as being right.

By Alex Volkov, Buzzrag Startup & VC Reporter